This distinction matters because 503B facilities face stricter FDA oversight, including current Good Manufacturing Practice (cGMP) requirements, than standard 503A pharmacies
Wegovy is FDA approved for weight management
Research Citations Ahmann A, Rodbard HW, Rosenstock J, et al
This medication is not recommended for use in people with glaucoma, hyperthyroidism, or a history of cardiovascular disease
While lower doses of semaglutide are available under other brand names, such as Ozempic (primarily used for managing type 2 diabetes), only the higher-dose Wegovy formulation is FDA-approved for weight management purposes
Special report: potential strategies for addressing GLP-1 and dual GLP-1/GIP receptor agonist shortages